Loading
AHF Stock: price and insider trades · Australia
AU·Mcap A$13.4M
AHF: what insiders have been doing
AHF is a listed company. Its directors and officers file their transactions with ASX. Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Insider buying of AHF has been absent for the past year.
Across the 2,535 companies tracked on its exchange, the median is 3 filings; at 2 filings, this issuer sits below that mark.
This summary is built from ASX disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 23,805 of 24,148 companies
8.3
score / 100
Value8
Quality8
FCF yld-32%
Earn yld-21%
EV/EBITDA·
ROE-12%
Gross mgn4.2%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
A$0.02
Analyst consensus
Income statement
RevenueA$7.1M
Gross profitA$297.4k4% margin
EBITDA-A$2.2M-31% margin
Net income-A$2.8M-39.7% margin
Valuation
P/Book0.6x
Beta-1.10
Balance sheet & cash
Market capA$13.4M
Total debtA$1.6M
Free Cash Flow-A$4.3M
Debt / Equity7%
Profitability & ownership
ROE-12.3%
ROA-8.9%
% insiders37.0%
% institutions5.4%
Last declaration on 10 July 2026
Declarations2 total
ShareASXASX:2924-03110021-3A696992
●
ShareASXASX:2924-03108475-3A696744
2 of 2 declarations
About AHF
AHF is a company listed on the XASX, specializing in the healthcare sector. It focuses on providing services and products related to public health.
